News Sentiment

DH sentiment intelligence

Definitive Healthcare Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 65 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 0.76 Week of 19 Jun 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 65

directly relevant articles

Source quality 9

high-authority source matches

Trend context Trend inactive

-9.5% over one week, -10.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Reflecting On Healthcare Equipment and Supplies Stocks’ Q1 Earnings: GE HealthCare (NASDAQ:GEHC)

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -9.5% Price reacting lower
Trend fit Trend inactive -10.8% over four weeks
Fair value -84.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 50
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 65
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 17
Seeking Alpha 6
Market source 6
TradingKey 5
Barron's 3
TradingView 2
The Globe and Mail 2
Sahm 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 22
Analyst action 3
Balance sheet 2
Capital return 1
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 65
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Oric Pharmaceuticals (ORIC) and Pfizer (PFE)

Analysts have provided new ratings for several healthcare companies. Bank of America Securities maintained a Buy rating for Omnicell (OMCL) with a $70.00 price target, while Wells Fargo maintained a Buy rating for Oric Pharmaceuticals (ORIC) with a $25.00 price target. Wells Farg

Tone
Neutral 50/100
Event
Analyst action
Published
12 Jun 2026 11:39
Source
The Globe and Mail
Stock Titan Direct company coverage

Director Hamood receives 189K RSUs at Definitive Healthcare (DH)

Definitive Healthcare director Samuel A. Hamood was granted 189,190 restricted stock units (RSUs) of Class A Common Stock at no cash cost. These RSUs are set to vest on the earlier of June 4, 2027, or the company's next annual stockholder meeting, contingent on his continued serv

Tone
Neutral 50/100
Event
Balance sheet
Published
09 Jun 2026 13:39
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare (DH) grants 189,190 RSUs to director Scott G. Stephenson

Definitive Healthcare (DH) director Scott G. Stephenson was granted 189,190 restricted stock units (RSUs) of Class A Common Stock. These RSUs will vest on the earlier of June 4, 2027, or the company's next annual stockholder meeting, conditional on his continued service. Followin

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare (DH) grants 189,190 RSUs to director Kathleen Winters

Definitive Healthcare Corp. (DH) reported that its director, Kathleen A. Winters, was granted 189,190 restricted stock units (RSUs) of Class A Common Stock. This equity grant, with no purchase price, increases her direct holdings to 308,982 shares. The RSUs are set to vest on the

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare (DH) director awarded 189,190 RSUs, holdings now 315,984 shares

Definitive Healthcare Corp. director Chilukuri Sastry was granted 189,190 restricted stock units (RSUs) on June 4, 2026, increasing his direct holdings to 315,984 shares. These RSUs are a compensation award with no purchase price and will vest on the earlier of June 4, 2027, or t

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare (DH) investors approve equity plan share increase and pay

Definitive Healthcare Corp. shareholders approved all proposals at their 2026 annual meeting, including the election of three Class II directors, the ratification of Deloitte & Touche LLP as independent auditor, and an increase of 15,000,000 shares to the 2021 Equity Incentive Pl

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare (DH) CEO sees 66,050 shares withheld for taxes

Definitive Healthcare (DH) CEO Kevin Coop had 66,050 shares of Class A Common Stock withheld at $0.99 per share to cover tax obligations related to the vesting of restricted stock units (RSUs). This transaction was a tax disposition, not an open-market sale, and represents a smal

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare (DH) CFO has shares withheld to cover RSU tax bill

Definitive Healthcare Corp.'s CFO, Casey Heller, had 164,377 shares of Class A common stock withheld by the company to cover tax obligations arising from vested restricted stock units (RSUs). This transaction, valued at $0.99 per share, was a tax-withholding disposition rather th

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Advent International holds 62,493,676 DH shares (NYSE: DH)

Advent International entities have reported beneficial ownership of 62,493,676 shares of Definitive Healthcare Corp.'s Class A common stock, representing 59.82% of the outstanding shares as of February 23, 2026. This ownership, detailed in a joint Schedule 13G/A filing, indicates

Tone
Neutral 50/100
Event
Market update
Published
14 May 2026 20:10
Source
Stock Titan
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Elanco Animal Health (ELAN) and Align Tech (ALGN)

This article summarizes analyst ratings for three healthcare companies: Definitive Healthcare Corp (DH), Elanco Animal Health (ELAN), and Align Tech (ALGN). Definitive Healthcare received a Hold rating from Canaccord Genuity, while Elanco Animal Health received a Buy rating from

Tone
Neutral 50/100
Event
Analyst action
Published
14 May 2026 04:40
Source
The Globe and Mail
Sahm Direct company coverage

Definitive Healthcare (DH) Posts US$9.3 Million Q4 Loss Testing Profit Turnaround Hopes

Definitive Healthcare (DH) reported a Q4 net loss of US$9.3 million and a full-year net loss of US$138.9 million on US$241.5 million in revenue, according to its latest FY 2025 earnings report. While Q4 saw a narrowed loss per share compared to earlier in the fiscal year, the com

Tone
Negative 29/100
Event
Earnings
Published
09 May 2026 13:08
Source
Sahm
The Manila Times Direct company coverage

Definitive Healthcare Reports Financial Results for First Quarter 2026

Definitive Healthcare announced its financial results for the first quarter of 2026, reporting revenue of $55.9 million and an Adjusted Net Income of $8.5 million, exceeding the high end of its guidance. The company highlighted improvements in retention rates and successful new c

Tone
Neutral 50/100
Event
Earnings
Published
08 May 2026 13:09
Source
The Manila Times
Stock Titan Direct company coverage

Massive goodwill hit but cash-positive quarter for Definitive Healthcare (DH)

Definitive Healthcare (DH) reported a Q1 2026 GAAP net loss of $192.4 million, significantly impacted by a $197.2 million goodwill impairment charge. Despite this, the company achieved positive non-GAAP profitability with Adjusted Net Income of $8.5 million and Adjusted EBITDA of

Tone
Neutral 50/100
Event
Earnings
Published
07 May 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Definitive Healthcare posts $192M Q1 loss on $197M impairment

Definitive Healthcare (NASDAQ: DH) reported a Q1 2026 net loss of $(192.4) million, primarily due to a $197.2 million goodwill impairment charge, despite revenue falling 6% year-over-year to $55.9 million. The company achieved adjusted net income of $8.5 million and adjusted EBIT

Tone
Negative 41/100
Event
Earnings
Published
07 May 2026 20:39
Source
Stock Titan